8 |
GLOBAL FLOW CYTOMETRY MARKET , BY APPLICATION ......................................................... 66 |
|||
• 8.1 |
INTRODUCTION ............................................................................................................................................................... 67 |
|||
• 8.2 |
RESEARCH APPLICATIONS .............................................................................................................................................. 67 |
|||
• 8.2.1 |
PHARMACEUTICAL AND BIOTECHNOLOGY ................................................................................................. 69 |
|||
• 8.2.1.1 |
DRUG DISCOVERY .................................................................................................................... 70 |
|||
• 8.2.1.2 |
STEM CELL RESEARCH ............................................................................................................ 71 |
|||
• 8.2.1.3 |
IN VITRO TOXICITY TESTING ................................................................................................... 73 |
|||
• 8.2.2 |
IMMUNOLOGY ............................................................................................................................................... 74 |
|||
• 8.2.3 |
CELL SORTING .............................................................................................................................................. 75 |
|||
• 8.2.4 |
APOPTOSIS .................................................................................................................................................... 76 |
|||
• 8.2.5 |
CELL CYCLE ANALYSIS ................................................................................................................................. 76 |
|||
• 8.2.6 |
CELL VIABILITY ............................................................................................................................................. 77 |
|||
• 8.2.7 |
OTHERS ......................................................................................................................................................... 78 |
|||
• 8.3 |
CLINICAL APPLICATIONS ................................................................................................................................................ 79 |
|||
• 8.3.1 |
CANCER ......................................................................................................................................................... 80 |
|||
• 8.3.2 |
HEMATOLOGY ............................................................................................................................................... 81 |
|||
• 8.3.3 |
IMMUNODEFICIENCY DISEASES .................................................................................................................. 82 |
|||
• 8.3.4 |
ORGAN TRANSPLANTATION .......................................................................................................................... 83 |
|||
• 8.3.5 |
OTHERS ......................................................................................................................................................... 84 |
|||
• 8.4 |
INDUSTRIAL APPLICATIONS ........................................................................................................................................... 85 |
|||
9 |
GLOBAL FLOW CYTOMETRY MARKET , BY END USER .............................................................. 86 |
|||
• 9.1 |
INTRODUCTION ............................................................................................................................................................... 87 |
|||
• 9.2 |
COMMERCIAL ORGANIZATIONS ..................................................................................................................................... 88 |
|||
• 9.3 |
MEDICAL SCHOOLS AND ACADEMIC INSTITUTIONS .................................................................................................... 89 |
|||
• 9.4 |
HOSPITALS ...................................................................................................................................................................... 90 |
|||
• 9.5 |
RESEARCH INSTITUTES ................................................................................................................................................... 91 |
|||
• 9.6 |
CLINICAL TESTING LABS ................................................................................................................................................ 92 |
|||